Profound anemia is highly prevalent across the limited-resource settings of sub-Saharan Africa, with data from the Fluid Expansion As Supportive Therapy (FEAST) trial demonstrating that 33% of children presenting for acute care to hospitals across Africa had Hb below this 5 g/dL threshold [18, 19]. The gene discussed is GSTM1; the disease is anemia.